2024
The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention
2021
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
Bikdeli B, Jiménez D, del Toro J, Piazza G, Rivas A, Fernández‐Reyes J, Sampériz Á, Otero R, Suriñach J, Siniscalchi C, Martín‐Guerra J, Castro J, Muriel A, Lip G, Goldhaber S, Monreal M, Monreal M, Prandoni P, Brenner B, Farge‐Bancel D, Barba R, Di Micco P, Bertoletti L, Schellong S, Tzoran I, Reis A, Bosevski M, Bounameaux H, Malý R, Verhamme P, Caprini J, Bui H, Adarraga M, Agud M, Aibar J, Aibar M, Amado C, Arcelus J, Baeza C, Ballaz A, Barba R, Barbagelata C, Barrón M, Barrón‐Andrés B, Blanco‐Molina Á, Botella E, Camon A, Cañas I, Casado I, Castro J, Chasco L, Criado J, de Ancos C, de Miguel J, del Toro J, Demelo‐Rodríguez P, Díaz‐Peromingo J, Di Campli M, Díez‐Sierra J, Domínguez I, Escribano J, Falgá C, Farfán‐Sedano A, Fernández‐Capitán C, Fernández‐Reyes J, Fidalgo M, Flores K, Font C, Font L, Francisco I, Gabara C, Galeano‐Valle F, Galindo D, García M, García‐Bragado F, de Herreros M, García‐Hernáez R, García‐Mullor M, García‐Raso A, Gavín‐Sebastián O, Gil‐Díaz A, Gómez‐Cuervo C, Grau E, Guirado L, Gutiérrez J, Hernández‐Blasco L, Hernando E, Herreros M, Jara‐Palomares L, Jaras M, Jiménez D, Jiménez R, Joya M, León J, Lima J, Llamas P, Lobo J, López‐Jiménez L, López‐Miguel P, López‐Núñez J, López‐Reyes R, López‐Ruiz A, López‐Sáez J, Lorenzo A, Madridano O, Maestre A, Marchena P, del Pozo M, Martín‐Guerra J, Martín‐Martos F, Mella C, Mellado M, Mercado M, Moisés J, Monreal M, del Valle Morales M, Muñoz‐Blanco A, Muñoz‐Rivas N, Navas M, Nieto J, Núñez‐Fernández M, Obispo B, Olid M, Olivares M, Orcastegui J, Ortega‐Michel C, Osorio J, Otalora S, Otero R, Parra P, Parra V, Pedrajas J, Pellejero G, Porras J, Portillo J, Riera‐Mestre A, Rivas A, Rivera‐Civico F, Rodríguez‐Chiaradía D, Rodríguez‐Cobo A, Rodríguez‐Matute C, Rogado J, Roig S, Rosa V, Ruiz‐Artacho P, Ruiz‐Giménez N, Ruiz‐Ruiz J, Ruiz‐Sada P, Salgueiro G, Sánchez‐Martínez R, Sánchez‐Muñoz‐Torrero J, Sancho T, Sirisi M, Soler S, Suriñach J, Tirado R, Torres M, Tolosa C, Trujillo‐Santos J, Uresandi F, Valero B, Valle R, Vela J, Vidal G, Villares P, Zamora C, Gutiérrez P, Vázquez F, Engelen M, Vanassche T, Verhamme P, Hirmerova J, Malý R, Salgado E, Abdallah N, Bertoletti L, Bura‐Riviere A, Crichi B, Debourdeau P, Olivier E, Falvo N, Farge‐Bancel D, Galliazzo S, Helfer H, Mahé I, Moustafa F, Poenou G, Schellong S, Braester A, Brenner B, Tzoran I, Bilora F, Bucherini E, Ciammaichella M, Di Micco P, Imbalzano E, Maida R, Mastroiacovo D, Pace F, Pesavento R, Pomero F, Prandoni P, Quintavalla R, Rocci A, Romualdi R, Siniscalchi C, Tufano A, Visonà A, Zalunardo B, Gibietis V, Kigitovica D, Skride A, Fonseca S, Martins F, Meireles J, Bosevski M, Bounameaux H, Mazzolai L, Bikdeli B, Caprini J, Tafur A, Ochoa‐Chaar C, Weinberg I, Wilkins H, Bui H. Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. Journal Of The American Heart Association 2021, 10: e021467. PMID: 34459215, PMCID: PMC8649245, DOI: 10.1161/jaha.121.021467.Peer-Reviewed Original ResearchConceptsAcute pulmonary embolismIncident atrial fibrillationPulmonary embolismAtrial fibrillationAcute symptomatic pulmonary embolismNew incident atrial fibrillationTiming of AFNew atrial fibrillationOutcomes of patientsSymptomatic pulmonary embolismAdverse clinical outcomesBackground Atrial fibrillationAF onsetCause mortalityMultivariable adjustmentIschemic strokeClinical outcomesMultivariable analysisAdverse outcomesPatientsMortalityStrokeEmbolismOutcomesFibrillation
2020
Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss
Brahmandam A, Gholitabar N, Cardella J, Nassiri N, Dardik A, Georgi M, Ochoa Chaar CI. Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss. Annals Of Vascular Surgery 2020, 70: 237-244. PMID: 32659417, DOI: 10.1016/j.avsg.2020.06.057.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmputation, SurgicalBenchmarkingChronic DiseaseComorbidityDatabases, FactualFemaleHospital MortalityHumansInpatientsIntermittent ClaudicationIschemiaMalePeripheral Arterial DiseaseQuality Indicators, Health CareRetrospective StudiesRisk AssessmentRisk FactorsTreatment OutcomeUnited StatesVascular Surgical ProceduresConceptsLower extremity revascularizationCharlson Comorbidity IndexRest painMajor amputationInpatient mortalityTissue lossEndovascular lower extremity revascularizationWorse short-term outcomesShort-term outcomesNational Inpatient SampleLength of stayMultivariable regression analysisComorbidity indexExtremity revascularizationPatient characteristicsMultivariable analysisInpatient SampleHigh comorbidityMean costPatientsAmputationMortalityTL groupOutcomesRevascularization
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply